COVID-19 and emerging viral infections: The case for interferon lambda

File
Piontkivska, H., Prokunina-Olsson, L., Alphonse, N., Dickenson, R., Durbin, J., Glenn, J., Hartmann, R., Kotenko, S., Lazear, H., O’Brien, T., Odendall, C., Onabajo, O., Santer, D., Reich, N., Wack, A., & Zanoni, I. (2020). COVID-19 and emerging viral infections: The case for interferon lambda. The Journal of experimental medicine. https://doi.org/https://doi.org/10.1084/jem.20200653
Piontkivska, Helen, Ludmila Prokunina-Olsson, Noémie Alphonse, Ruth Dickenson, Joan Durbin, Jeffrey Glenn, Rune Hartmann, Sergei Kotenko, Helen Lazear, Thomas O’Brien, Charlotte Odendall, Olusegun Onabajo, Deanna Santer, Nancy Reich, Andreas Wack, and Ivan Zanoni. 2020. “COVID-19 and Emerging Viral Infections: The Case for Interferon Lambda”. The Journal of experimental medicine. https://doi.org/https://doi.org/10.1084/jem.20200653.
Piontkivska, H., L. Prokunina-Olsson, N. Alphonse, R. Dickenson, J. Durbin, J. Glenn, R. Hartmann, S. Kotenko, H. Lazear, T. O’Brien, C. Odendall, O. Onabajo, D. Santer, N. Reich, A. Wack, and I. Zanoni. COVID-19 and Emerging Viral Infections: The Case for Interferon Lambda. The Journal of experimental medicine, 14 Apr. 2020, doi:https://doi.org/10.1084/jem.20200653.